首页|中医药联合化疗和靶向治疗晚期肠癌的研究进展

中医药联合化疗和靶向治疗晚期肠癌的研究进展

扫码查看
结直肠癌作为临床常见的恶性肿瘤严重威胁着人类健康,目前大量研究证实中医药在协同化疗和靶向治疗上发挥着独特优势,中西医结合治疗已成为治疗晚期结直肠癌的新模式,为晚期结直肠癌治疗提供了更多的治疗途径和思路。文章通过检索相关临床文献,对其进行探讨和分析,针对中医药对晚期结直肠癌化疗,联合靶向治疗的临床研究现状进行综合分析。文献研究发现中医药可有效提高晚期结直肠癌化疗联合靶向治疗患者的近期和远期临床疗效,并在提高机体免疫功能、减轻毒副作用等方面有着重要作用。
Evidence-Based Medicine Review of TCM in Combination with Chemotherapy and Targeted Therapy for Advanced Colorectal Cancer
The common colorectal cancer(CRC)threatens human health.At the moment,it has been frequently confirmed that TCM shows synergy with chemotherapy and targeted therapy.The combination of TCM and western medicine has become a new mode for the treatment of advanced CRC,providing more treatment approaches and ideas.In this study,relevant articles were retrieved from China National Knowledge Infrastruc-ture(CNKI),VIP,Wanfang Data,and PubMed(from inception to December 30,2022)and analyzed.On this basis,the clinical research on TCM in combination with chemotherapy and targeted therapy for advanced CRC was dissected.Literature research shows that TCM can effec-tively improve the short-term and long-term clinical efficacy of chemotherapy combined with targeted therapy for patients with advanced CRC and plays an essential part in reducing toxic and side effects and improving immune function.

Traditional Chinese medicineColorectal cancerChemotherapyTargeted therapy

田园、杨忠明、衡鑫、沈程明、段大跃

展开 >

西南医科大学中西医结合学院,泸州 646000

西南医科大学附属中医医院中医药表型组学研究中心,泸州 646000

西南医科大学附属中医医院肿瘤科,泸州 646000

中医药 肠癌 化疗 靶向治疗

泸州市人民政府-西南医科大学高层次人才(段大跃团队)引进专项国家中医药局中医药循证能力建设项目泸州市人民政府-西南医科大学科技战略合作项目

2019LZXNYD-P01DUAN2019XZZX-ZL0052018LZXNYD-ZK37

2024

中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

北大核心
影响因子:0.996
ISSN:1001-859X
年,卷(期):2024.40(3)
  • 40